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Typical matureT cells display a subtle form of specificity for the H-2 molecules
encountered in the thymus during ontogeny : extrathymic T cells respond well to
selfH-2 molecules complexed to exogenous antigens but generally cannot be trig-
gered by selfH-2 molecules per se.T cellswith overt auto-H-2 reactivity areevident
during the early stages of thymocyte differentiation, but these cells are destroyed
in situ and rarely ifever reach the secondary lymphoid tissues (1). The mechanisms
leading to the deletion of self H-2-reactive T cells in the thymus are poorly under-
stood, and it is still unclear which particular cell typescontrol this process (2). There
is generalagreement, however, that tolerance induction is controlled largely by bone
marrow (BM)t-derived cells, especially APC such as macrophages and dendritic
cells . Whether thymic epithelial cells contribute to tolerance induction is controver-
sial . Most groups agree that the main function of thymic epithelium is to control
positive selection ofT cells, i.e ., the preferential survival ofTcells that display significant
("physiological") specificity for the particular H-2 molecules expressed on thymic
epithelium (3-7).A key question is whether thymic epithelial cells convey only posi-
tive signals to T cells or are also capable of providing negative signals . The bulk
of evidence suggests that thymic epithelial cells play only a minor role in tolerance
induction (2, 8-12). In particular, studies with fetal thymus grafts depleted ofAPC
imply that thymic epithelial cells are incapable of tolerizing CD8` CTL precursors
(9-11) . Nevertheless, studies with other model systems are difficult to reconcile with
the view that thymic epithelium is completely nontolerogenic (13-17) .
Ourinterest in thequestion ofwhich cell types control tolerance induction stemmed
from the finding that T cells generated in irradiated H-2-heterozygous (a x b)F1
mice reconstituted with a mixture of parent a plus parent b BM cells showed com-
plete tolerance to the APC of the opposite parental strain (18, 19) . If the presence
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of BM-derived cells was mandatory for tolerance induction, it was reasoned that
reconstituting irradiated F, mice with BM cells of only one parental strain would
not lead to tolerance induction. In this situation, the disappearance of host APC
after irradiation would preclude tolerance induction to the host alloantigens, with
the result that the donor-derived T cells differentiating in the host thymus would
show strong reactivity to host-type APC in vitro. In practice, these chimeras dis-
played a form of split tolerance (20, 21). The donor T cells showed complete toler-
ance to the host in terms of CTL activity, but gave low but significant antihost re-
sponses in MLR.
Since the dose of irradiation used to prepare the chimeras used in the above stud-
ies was only 900 rad, the tolerance seen in the chimeras could have reflected T cell
contact with residual host APC. Alternatively, tolerance might have been induced
by non-BM-derived cells, e.g., thymic epithelial cells. To try to distinguish between
these two possibilities, we have studied T cell tolerance in chimeras prepared with
supralethal irradiation. Despite the apparent absence of host-type APC, the donor
T cellsdifferentiating in these chimeras show considerable (though nottotal) toler-
ance to host H-2 determinants in functional assays. ThechimeraT cells also display
extensive clonal deletion of host-reactive VOW cells. Since tolerance in the chime-
ras is prominent at the level of thymocytes, the data support the view that aradiore-
sistant non-BM-derived component ofthe thymus, presumably thymic epithelium,
can play a conspicuous role in tolerance induction.
Materials and Methods
Mice.
￿
Young (6-8 wk) (B6 x CBA/J)F, mice were purchased from TheJackson Labo-
ratory, BarHarbor, ME. Young(6-8 wk) CBA/Ca, BALE/c, AKR/J, C57BL/6(B6), B6.PL
Thy-1°, B10.BR, B6.C-H-2nm, (burl), B6.C-H-2nm,2 (bm12), and (B6 x CBA/Ca)F, mice were
bred at the Research Institute of Scripps Clinic.
Irradiation.
￿
Mice were exposed to various doses of irradiation from a "Cs source (85
rad/min) delivered by a Gammacell 40 irradiator (Atomic Energy of Canada Ltd., Ottawa,
Canada). Cells were exposed to 1,500 rad of irradiation from a '''Cs source delivered by a
Gammacell 1000 irradiator (Atomic Energy of Canada Ltd.).
Media.
￿
HBSS supplemented with 2.5 17o gammaglobulin-free horseserum(Gibco Labo-
ratories, GrandIsland, NY) wasused forpreparation of single cell suspensions. RPMI 1640
supplemented with 10% FCS (Irvine Scientific, Santa Ana, CA), 5% NCTC 109, 2 mM
glutamine, 5 x 10-5 M 2-ME, and antibiotics was used for culturing cells in vitro. HBSS
supplemented with 1% gamma globulin-free horse serum (Gibco Laboratories) and 0.1%
sodium azide(Sigma Chemical Co., St. Louis, MO) was used forimmunofluorescent staining.
mAbs.
￿
The followingmAbs were used: antiThy-1.2 (J1j, ratIgG, ascites) (22); non-allele-
specific antiThy-1 (T24, rat IgM, ascites) (23); anti-B cell (Jlld, rat IgM, culture superna-
tant) (22); anti-CD4 (GK1 .5, rat IgG2b, ascites) (24); anti-CD8 (3.168.8, rat IgM, ascites)
(25); anti-I-AMd) (28-16-8S, mouse IgM, ascites) (26); anti-I-A'0-."') (10.2 .16, mouse IgG2b,
ascites) (27); anti-class I K'D' (16-1-2N, mouse IgG2a, ascites) (28); antiVo11 (RR3-15, rat
IgG, ascites) (29); antiVs8.1 + 8.2 (KJ16-133, rat IgG2; ascites) (30); anti-CD3 (145-2C11,
hamster, ascites) (31) .
Preparation ofChimeras.
￿
BM chimeras were prepared by injecting 5-10 x 10' antiThy-1
rnAb plus C-treated (32) parental H-2-type BM cells into (B6 x CBA/J)F, mice subjected
to an unfractionated dose of 1,300 rad irradiation 4-10 h before. Some mice received asecond
dose ofirradiation (850-1,000 rad) plusT-depleted BM cells at 2-5 mo afterinitial reconstitu-
tion. In some experiments, chimeras were reconstituted with day 13 fetal liver cells; these
cells were treated with a mixture of antiThy-1, anti-CD4, and anti-CD8 mAb + C before
transfer. All chimeras were maintained on antibiotics added to the drinking water.
Purification of T Cell Subsets.
￿
Extrathymic T cells were purified from lymph nodes (LN)GAO ET AL.
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using pooled cervical, axillary, inguinal, and mesenteric nodes. Cell populations containing
90-95% CD4' cells were prepared by treating LN cells with Jlld plus anti-CD8 mob +
C (33); similarly, populations enriched for CD8* cells were prepared by treating LN with
Jlld plus anti-CD4 mob + C. CD8- thymocytes were prepared by treating thymocytes with
anti-CD8 mob + C.
Stimulators for Mixed Lymphocyte Reactions (MLR).
￿
In most experiments, antiThy-1 plus
C-treated spleen cells were used as stimulators (33). In some experiments, thymus suspen-
sions were enriched for APC by separation on Percoll gradients (33, 34).
MLR.
￿
Doses of 0.5-2 x 105 responder cells were cultured in flat-bottomed microtiter
plates with 5 x 105 irradiated (1,500 rad) antiThy-1 + C-treated spleen cells as stimulators
in a volume of 200 ,1, and then pulsed with 1 pCi ['H]TdR 18 h before harvest (33). The
data shown in the tables refer to the mean responses of triplicate cultures.
Blocking ofMLR with Anti-IA mob. To seek information on the relative affinity of the re-
sidual host-reactive CD4' cells in parent --, F, chimeras, doses of 2 x 105 CD4' cells from
k -+ (b x k)F, chimeras were cultured with APC (5 x 105 irradiated T-depleted spleen) ex-
pressing host-type H-2n antigens in the presence of various concentrations of anti-I-A' mob.
In parallel, graded concentrations ofanti-I-A' mob were added to control cultures contain-
ing H-2b APC plus 5 x 104, 105 , or 2 x 105 normal H-2k CD4' cells. MLR were harvested
on days 4, 5, and 6. Since the response of the chimera CD4' cells was substantially lower
than the response of the control CD4' cells, the inhibitory effect of the anti-I-A' mob was
analyzed only in cultures in which the control responses for each cell type (the responses
obtained in the absence of mob) were approximately the same in terms of change in (A)
cpm. Thus, to compare the inhibition seen with the dose of 2 x 105 chimera CD4' cells,
it was necessary to make a comparison with cultures containing a lower dose of the control
CD4' cells, e.g., 5 x 104 or 1 x 105. The percent inhibition of MLR by the anti-I-Ab mob
was calculated according to the formula: percent inhibition = 100 x [1-(A cpm with mob/A
cpm without mob)]. Control cultures in which anti-I-Ab mob was added to cultures con-
taining H-2k CD4' cells and H-2" (SJL) stimulators gave no inhibition.
AssayforLethal Graft-as:Host Disease (GHVD).
￿
Adult mice aged 10-12 wk were exposed to
heavy irradiation (1,000 rad) 4-5 h before transfer of T cells and antiThy-1 plus C-treated
host marrow cells intravenously. Mice were inspected three times per week until death, or
for 100 d. No antibiotics were given to the mice.
Skin Grafting .
￿
Ear or tail skin grafts were applied to the flank region by the method of
Billingham (35).
Preparation ofCortisone-resistant Thymocytes (CRT).
￿
Mice were injected intraperitoneally with
5 mg/mouse cortisone acetate (Merck, Sharp, and Dohme, West Point, PA) 18 h before re-
moving the thymus.
Immunofluorescent Staining and FACS Analysis,
￿
To search for host-derived lymphohemato-
poietic cells in parent - F, chimeras, lymphoid cells (0.5-1 x 106) from b - (b x k)F, chi-
meras were first stained with an antibody specific for host H-2 class I molecules (anti-KkDk)
followed by FITC-labeled goat anti-mouseIg (anti-Mig) ,y chain-specific antibody (CooperBio-
medical, Inc., Malvern, PA). Afterextensive washing, the cells were then stained with biotin-
ylated anti-Thy-1.2 mob or biotinylatedJlld mob followed by phycoerythrin (PE)-streptavidin
(Biorneda Carp Poster City, PA), Doses of 104 fresh (unfixed) cells were analyzed on a FACS
IV flow cytometer (Becton Dickinson Immunocytometry Systems, Mountain View, CA).
To detect T cells expressing VQ TCR molecules, lymphoid cells were stained with various
anti-V# TCR mobs followed by FITC-labeled H and L. chain-specific affinity-purified F(4V)2
fragments ofmouse anti-rat IgG (Pel-Freez Biologicals, Rogers, AR) or FITC-labeled anti-
CD3 mob, In most experiments, the cells were then stained with PE-labeled anti-CD4 mob
(Becton Dickinson d[ Co., Mountain View, CA), In some experiments, biotinylated anti-
CD8 mob followed by PE-labeled streptavidin was used for secondary staining.
Results
Unless stated otherwise, BM chimeras were prepared by exposing adult (B6 x
CBA/J)Fi (H-2h x H=24) mice to an unfractionated dose of very heavy gamma ir-
radiation, i.e., 1,300 rad, followed by reconstitution with T-depleted parental strain1104
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(or parental H-2 type) stem cells, usually BM cells. Some chimeras received a sec-
ond dose of irradiation (850-1,000 rad) given at 2-5 mo afterinitial reconstitution.
The survival of the chimeras was quite high (>90%), even for twice-irradiated chi-
meras. T cell regeneration in twice-irradiated chimeras was slow, and it was neces-
sary to leave these chimeras for at least 2 mo in order to obtain sufficient T cells
for functional assays.
To avoid confusion, it should be mentioned that many of the chimeras were pre-
pared across a combined H-2 plus strong Mls (Mlsa) barrier, the intention being
to examine tolerance to both antigens simultaneously. For simplicity, only the data
on H-2 tolerance are presented in this paper.
Depletion ofHost Lymphohematopoietic Cells.
￿
When parent - F1 chimeras prepared
with a single dose of 1,300 rad were tested at >2 mo after reconstitution, cryostat
sections ofthe spleen, LN, gut, and skin showed avirtual absence of cellsexpressing
a high density ofhost la molecules (not shown). Host la expression was clearly de-
tectable on the cortical epithelial cells of the thymus and was conspicuous on scat-
tered aggregates of cells in the thymic medulla. Based on several criteria, including
double staining with antikeratin reagents, the medullary cells with high host la ex-
pression appeared to be a subset of epithelial cells. A full description of these cells
will be published elsewhere.
Although previous work with BM chimeras prepared with -1,000 rad showed that
host APC disappeared rapidly after irradiation (5, 32, 36), minor survival of host
APC could not be excluded. To search for functional APC in chimeras given 1,300
rad, lymphoid cells from the chimeras were tested for their capacity to stimulate
MLR by normal parental strain CD4+ cells. As exemplified by the experiments
shown in Table 1, even high doses of spleen cells or thymocytes from the chimeras
failed to stimulate normal donor strain CD4+ cells, but were strongly immunogenic
for CD4+ cells from the opposite parent.
To search for host-derived T and B cells in the chimeras, lymphoid suspensions
of long-term B6 (H-2b) -+ Fi chimeras were stained for expression of host H-2K/Dk
molecules vs. Thy-1 or J11d (a B cell marker) using two-color immunofluorescence
and FACS analysis. A typical experiment is shown in Fig. 1. Host-derived H-2K/Dk+
cells were very rare in the thymus (<0.5%) (not shown) but accounted for N4% .of
spleen cells and N7% of LN cells(Fig. 1, a-c). These cells consisted almost entirely
of radioresistant T cells, since >95% of the cells were Thy-1+ andJlld- . These host-
derived T cells disappeared when the chimeras were subjected to a second dose of
irradiation (Fig. 1, d-fi. To establish the origin of the T cells developing in these
double-irradiated chimeras, the BM cells used for secondary reconstitution carried
a Thy-1 marker. For example, B6 - Fi (Thy-1.2 --" Thy-1.2) chimeras were reirra-
diated and reconstituted with Thy-l-incompatible B6.PL Thy-la (H-2b, Thy-1.1) BM
cells. These chimeras will be abbreviated "B6.PL - (B6 - Fi)." The lymphoid cells
recovered from these chimeras at 3 mo after secondary reconstitution contained
<0.2% host-derived H-2K/Dk+ cells, although significant numbers of Thy-1.2+ cells
were found in spleen (3%) and LN (7%) (Fig. 1, d and e). These Thy-1.2+ H-2K/Dk-
cells were almost undetectable in thymus (Fig. 1J) and were presumably radioresis-
tant cells derived from the B6 BM cells used for initial reconstitution of the chime-
ras. The majority of the LN cells in B6.PL -" (B6 --> Fl) chimeras appeared to be
T cells derived from the second dose of BM cells (B6.PL), since -70% of the cellsGAO ET AL.
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TABLE I
Capacity of Lymphohematopoietic Cellsfrom Parent - F1 BM Chimeras
to Stimulate Primary MLR: Failure to Detect APC of Host Origin
[3H]TdR
incorporation with
The bone marrow chimeras (BMC) were tested at 2 mo after irradiation and
BM reconstitution. Responder cells were CD4' cells prepared from LN (2 x
105/well). The stimulator cells in Exp. 1 were prepared from thymus using sepa-
ration on Percoll gradients; the cells used for stimulators were taken from the
61 .07 band of the Percoll gradients. The stimulators in Exp. 2 were anti-Thy-1
+ C-treated spleen cells. All stimulators were irradiated (1,500 rad). MLR were
harvested on day 4 ofculture. The data show mean responses oftriplicate cultures.
were JIM - Thy-1.2 - and expressed either CD4 or CD8 molecules (not shown). The
cells were not typed for Thy-1.1.
For functional studies with B6.PL - (B6 - F1) chimeras, the LN Tcells from
these mice were treated with antiThy-1.2 mAb + C before use, thereby ensuring
that the T cells were derived from the second dose ofBM cells. Similar treatment
was used to prepare T cells from reirradiated CBA/Ca -" F1 chimeras (Thy-1.2 ->
Thy-1.2) reconstituted with AKR/J (H-2k, Thy-1.1) BM cells [AKR/J --" (CBA/Ca
--> F1) chimeras].
MLR by LN CD8' Cells.
￿
Purified LN CD8+ cells from parent - F1 chimeras
invariably showed completetolerance tohost-type H-2 determinants inprimary MLR
± rIL-2. The possibility that tolerance reflected contact with class I molecules on
residual host T cells seems unlikely, since full tolerance was observed with twice-
irradiated chimeras, i.e., mice containing no detectable host T cells. Similar toler-
ance was observed when long-term chimeras were given a large dose of opsonizing
antiThy-1 mAb (37) to remove mature T cells (including host T cells) and then al-
lowed to regenerate a new wave ofCD8+ cells (Table II).
Exp.
Stimulators
Strain
Tissue
source
No. of
stimulators
x 10-'
CD4'
B6.PL
(H-26)
cpm
responders
CBA/Ca
(H-2k)
x 103
1 B6.PL Thymus 4 2 .0 65.4
CBA/Ca Thymus 4 34.1 3.6
(B6 x CBA/Ca)Fl Thymus 4 58.6 49 .2
B6.PL - F, BMC Thymus 4 1 .9 37 .0
B6 AKR/J
(H-2b) (H-2k)
2 B6 Spleen 0.2 0.3 3 .8
1 0.8 24.9
5 2 .3 99 .9
10 2.3 51 .6
AKR/J Spleen 0.2 6.0 0.4
1 41 .7 0.9
5 138.1 2.5
10 79.4 3.7
AKR/J - F, BMC Spleen 0.2 1 .7 0.3
1 31 .2 0.5
5 52.7 1 .7
10 109.3 2.21106
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FIGURE 1.
￿
Origin of lymphoid cells in parent - F, chimeras. Lymphoid cells from b -+ (b x
k)F, chimeras given a single dose of irradiation (a-c) or double irradiation (df) were stained
with anti-KkDk(anti-host H-2 class 1) mAb plus FITC anti-Mig (y-axis) followed by biotinyl-
ated antiThy-1.2 mAb or Jlld mAb plus PE-streptavidin (x-axis) and analyzed on a FAGS IV
usingtwo-channel immunofluorescence (Materials and Methods). Lymphoid cells from normal
(B6 x CBA/J)F, mice (g-:) and normal B6 mice (j-0 were stained as controls. The B6 ~ F,
chimera givena single dose of irradiation (a-c) wastested at 5 mo after reconstitution. It is evi-
dent that the spleen and LN ofthis chimera containeddetectable numbers of host-derived KkDk+
B6
a Spleen b
W
U H U H
WGAO ET AL.
TABLE II
MLR by Purified CD8' Cellsfrom B6.PL --" Fi BMC:
Full Tolerance to Host-type H-2 Determinants t rIL-2
BMC were depleted of mature T cells at 2 mo post-irradiation by injection of
opsonizing anti-Thy-1 mAb (0.2 ml of T24 ascites fluid) (37). The mice were
then left for 3 mo to generate a new wave of T cells. Purified LN CD8' cells
(Materials and Methods) were used as responders (2 x 105/well) in MLR us-
ing T-depleted irradiated (1,500 rad) spleen cells (5 x 105/culture) as stimula-
tors; to inhibit the responses of any residual CD4' cells in the CD8' cell
preparation, the cultures were supplemented with anti-CD4 mAb (0.1 % of as-
cites fluid). rIL-2 (kindly provided by Cetus Corp., Emeryville, CA)wasadded
to the cultures where indicated . Since CD8' cells respond selectively to H-2 class
I alloantigens, la-compatible class I (H-2K)-incompatible bml stimulators were
used as a third-party control. MLR were measured on day 3 . The data show
mean responses of triplicate cultures.
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MLR by LN CD4` Cells.
￿
LN CD4+ cells from parent - Fl chimeras invariably
gave low but significant MLR toAPC expressing host-typeH-2 determinants. How-
ever, the magnitude ofthis "antihost MLR" was always considerably less than the
response of normal parental strain CD4+ cells. The features of the antihost MLR
can be summarized as follows.
The magnitude of the antihost MLR by the chimera CD4+ cells was generally
in the range of 10-50% ofthe response given by normal parental strain CD4+ cells.
This was established by comparing the MLR ofthe chimera cells with the MLR
given by graded doses of normal CD4+ cells or CD4+ cells taken from syngeneic
chimeras (Table III, Exps. 1 and 3; Fig. 2). The response ofthe chimera CD4` cells
showed the typical kinetics ofunprimed T cells with peak responses being observed
on day6 orlater (Fig. 2A). The MLR ofthe chimera cells tohost-type H-2 determi-
cells (4% in spleen and 7% in LN). Since >95% of the KkDk' cells in the chimera were Thy-
1.2' andJlld- (a-c), the cells were presumed to be radioresistant host T cells. These host cells
were extremely rare in chimeras given a second dose ofirradiation (d-f). Thechimera illustrated
was initially reconstituted with B6 BM, left for 2 mo, and then exposed to 850 rad followed by
reconstitution with Thy-1.1' B6.PLThy-la BM cells; lymphoid cells were prepared at 3 mo af-
ter secondary reconstitution. It is evident that the proportion of KkDk, lymphoid cells in this
twice-irradiated chimera wasalmost undetectable (40.2%) in spleen, LN,and thymus (df). How-
ever, the chimera did contain significant numbers of Thy-1.2' cells (4% in spleen, 7% in LN,
and 0.4% in thymus). Since these Thy-1.2' cells were KkDk-, the cells were presumed to be ra-
dioresistant T cells derived from the initial inoculum of B6 (Thy-1.2) BM cells.
Donors of
purified
CD8' cells
Addition
of rIL-2
(3 U/ml)
to MLR
f3H)TdR incorporation
with spleen stimulators
B6.PL B10.BR
(H-2h) (H-2k)
bml
(H-2bm1)
cpm x 103
B6 .PL - F, BMC - 0.9 1 .2 32.7
+ 5.5 7.9 58.6
Normal B6 .PL 1 .1 91.2 104.4
8.7 164.7 152.5
Normal (B6 x CBA)F1 1 .1 0.8 91 .1
10.9 10.7 149.71108
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TABLE III
MLR by IN CD4+ Cells from Parent -" Fi BMC: Incomplete Tolerance to Host H-2 Determinants
[3H]TdR incorporation with spleen stimulators
The five experiments illustrated each contain data on BM chimeras prepared with a single dose of 1,300
rad; these chimeras were tested at 4 to 8 mo post-reconstitution. The twice-irradiated chimeras used in Exps.
1 and 2 received the second dose of irradiation at 3 mo after the first dose and were assayed at 3 mo after
the second dose. In Exp. 1, the AKR/J - (CBA/Ca - F,) chimeras were reconstituted with CBA/Ca BM
cells after the first dose of irradiation and with AKR/J BM cells after the second dose; the CD4' cells pre-
pared from these chimeras were treated with anti-Thy-1 .2 mAb + C in vitro before culture. The twice-irradiated
chimeras in Exp. 2 were reconstituted with CBA/Ca BM cells after each dose of irradiation. The chimeras
shown in line 2 of Exp. 2 received a single large dose of opsonizing anti-Thy-I mAb (see Table II) at 2 mo
post-irradiation and were tested 4 mo later. In Exp. 3, the chimeras reconstituted with BM cells taken from
both parental strains were tested at 3 mo post-transfer, and the LN responders were treated with anti-H-26
mAb + C to obtain H-2k (CBA/Ca)-derived cells. The chimeras shown in line 2 of Exp . 5 were injected
with anti-I-Ak mAb (0.1 ml of 10.2 .16 ascites fluid) on days 1, 4, and 7 of the first week after irradiation
and tested 6 mo later. For each experiment, CD4' cells were purified from individual chimeras. The data
show MLR measured on day 5.
nants could be stimulated by either host-type F1 APC or by APC of the opposite
parent (Table III). With chimeras prepared with H-211 BM, responses were repro-
ducibly higher to APC ofthe opposite parent than to host-type APC (e.g., Table
III, Exp. 4); the reverse applied to reciprocal H-2b - F1 chimeras (e.g., Table III,
Exp. Donors of purified CD4' cells
No. of
responders
x 10-'
AKR/J
(H-2k)
B6
(H-2i')
cpm x 10 j
BALB/c
(H-2,1)
1 AKR/J - F, BMC 2 0.7 18.8 170.2
AKR/J - (CBA/Ca - F,)
13MC 2 1 .1 34.5 160.5
AKR/J - AKR/J BMC 0.5 0.4 23.1 10.4
1 0.6 94.7 42.4
2 2.1 133.6 152.5
CBA/Ca B6 BALB/c
(H-2k
) (H-2r
') (H-2d)
2 CBA/Ca - F, BMC 1 2.4 12.3 106.5
CBA/Ca - F, (anti-Thy-1
mAb) BMC 1 2 .8 9.2 84.5
CBA/Ca -" (CBA/Ca - F, )
BMC 1 1 .2 13.2 97.9
Normal (B6 x CBA/J)F, 1 2.1 0.9 93.3
BIO.BR B6 BALB/c
(H-2tk) (H-2') (H-2d)
3 CBA/Ca + B6 -" F, BMC 2 3 .6 3 .6 59.8
CBA/Ca - F, BMC 2 1 .4 18 .6 109.4
Normal CBA/Ca 0.5 0.6 4 .6 6.4
1 1 .4 18 .9 18.4
2 3.6 57 .2 87 .3
BIO.BR B6 (B6 x CBA/Ca)F, BALB/c
(H-2k) (H-26) (H-2b
x H -2k) (H-2d)
4 C13A/J -" F, BMC 2 3 .2 35 .8 11 .4 109.3
Normal CBA/J 2 6 .8 94.3 60.5 105.3
5 B6 -" F, BMC 2 8.9 2 .4 15.2 89.0
B6 - F, (anti-I-Ak mAb) BMC 2 8.3 1 .8 20.7 97.4
Normal B6 2 39.0 7 .8 69.4 70.170
60
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40
30
20
10
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FIGURE 2.
￿
Kinetics of the antihost
MLR by CD4' cells from a B6 --" F,
chimera. LN CD4' cellsfrom the chi-
merawere obtained at 4mo afterirra-
diation and BM reconstitution. Doses
of 2 x 105chimeraCD4' cells (A)vs.
0.5 x 105 or 105normal B6 CD4' cells
(B and C) were cultured with 5 x 105
irradiated (1,500 rad) T-depleted spleen
stimulator cells takenfrom normal B6
(p), CBA/Ca ("), or BALB/c mice
(O). Cultures were harvestedon days
4, 5, and6. It canbe seen that theanti-
CBA/Ca response produced by the
dose of 2 x 105 B6 -+ F, chimera
CD4' cells closely resembled the anti-
CBA/Ca response given by thedose o£
0.5 x 105 normal B6 CD4' cells, both
in terms of the magnitude of the re-
sponse andthe kinetics ofthe response.
Exp. 5). These patterns closely paralleled the responses of normal H-26 vs. H-2k
CD4' responders. Comparing the response to H-2-congenic B6 vs. B10.BR APC
confirmed that the antihost MLR was directed to H-2 determinants rather than to
non-H-2-encoded antigens (Table III). Note thatnone ofthe APC expressed strong
Mls differences with respect to the responder cells.
Various manipulations designed to deplete the chimeras ofany residual host-type
APC had only minimal effects in increasing the magnitude of the antihost MLR.
These manipulations included: (a) leaving the chimeras for up to 1 yr post-
reconstitution and/or allowing new T cells to form in antiThy-1 mAb-treated chi-
meras; (b) injectingthe chimeras repeatedly with anti-host la mAb during the first
week post-reconstitution; and(c) subjecting the chimeras todouble irradiation. None
ofthese procedures reproducibly caused more than a minor increase in the antihost
MLR (Table III). It should be noted that no antihost MLR was seen with T cells
from double BM chimeras, i.e., chimeras prepared by reconstituting F, mice with
a mixture of BM cells taken from both parental strains (Table III, Exp. 3).
Toassess the possibility that the antihost MLR reflected clonal expansion ofresid-
ual mature T cells in the donor marrow (which was routinely treated with a high
dose of antiThy-1 mAb + C), we prepared chimeras with day 13 fetal liver cells.
Like BM chimeras, these fetal liver chimeras showed incomplete tolerance to host
H-2 determinants. In the experiment with fetal liver chimeras illustrated in Table
IV, the antihost response by a dose of 2 x 105 chimera CD4' cells was equivalent
to the response ofa two- to threefold lower dose ofcontrol CD4' cells (CD4+ cells
from syngeneic chimeras).
Inhibition ofMLR by Anti-Ia mAb.
￿
To seek evidence on the relative affinity ofthe
T cells eliciting the antihost MLR, graded doses ofanti-host I-Ab mAb were added
to cultures containing B6 (I-Ab I-E-) stimulators and H-2'-derived chimera CD4+
responders (Fig. 3). CBA/Ca -> F, and AKR/J -" Ft chimeras were used for these
studies. For controls, anti-I-A' mAb was added to B6 stimulators cultured with nor-
mal CBA/Ca or AKR/J -AKR/J CD4' responders. To produce responses ofcom-
parable magnitude (A cpm), the control CD4' responder cells were used in two-1110
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To prepare fetal liver chimeras (FLC), CBA/Ca - 1,300 rad (B6 x CBA/J)Fl BM chimeras were left for
a period of 5 mo, exposed to 900 rad, and reconstituted with day 13 AKR/J fetal liver (FL) cells treated
with a mixture of anti-CD4, anti-CD8, and anti-Thy-1 (T24) mAb + C (Materials and Methods). CD4'
cells were prepared from the chimeras at 4 mo after FL reconstitution and were treated with anti-Thy-1 .2
mAb + C before use. The control FLC were prepared by transferring FL cells to syngeneic AKR/J mice
exposed to a single dose of 1,300 rad.
A
￿
0
￿
C
￿
FIGURE 3 .
￿
Susceptibility ofthe anti-
host MLR by chimera CD4' cells to
inhibition with anti-host I-A mAb. As
described in Materials and Methods,
doses of 2 x 10,5 chimera H-2k CD4'
cells were cultured with 5 x 105 irra-
diated B6 (H-26
) spleen stimulators
plus graded concentrations of anti-1-
A" mAb. Parallel cultures were set up
with three different doses ofnormal 136
CD4' responders, i.e., 5 x 104, 105,
and 2 x 105. Comparison of the inhib-
itory effects ofthe anti-I-Ab mAbwas
made only when the control response
ofthe chimera CD4' cells wascompa-
rable in magnitude (A cpm) with the
control response given by one ofthe three doses of normal 136 responders. Since MLRwere harvested
on three different days (days 4-6), it was possible to make up to three comparisons/experiment for each
chimera tested. The data shown were derived from three separate experiments conducted on a total
of five chimeras (one chimera in A, with one comparison made on day 5 of MLR; onechimera in B,
with two comparisons [mean shown] made on day 5 and 6 of MLR; and three chimeras in C, with
three comparisons [mean shown] made on day 5 of MLR). In each experiment, it is evident that the
antihost (anti-B6) MLRby the chimera CD4' cells was more easily inhibited with anti-I-Ab mAb than
the anti-B6 MLR mediated by normal CBA/Ca CD4' cells. The increased inhibition of the response
of the chimera CD4' cells was most prominent when intermediate doses of mAb were used, i.e., doses
sufficient to cause -50% inhibition of the response of the control CD4' cells. It should be noted that
the doses of anti-I-Ab mAbused caused no inhibition of the response to SJL(H-25) APC (not shown).
All of the chimeras were tested at 3-4 mo after BM reconstitution. The double-irradiated chimeras
in B were tested at 3 mo after the second dose of irradiation.
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TABLE IV
Antihost MLR by LN CD4' Cells from Twice-irradiated parent - F, Chimeras
Prepared with Fetal Liver Cells
OAKR/J"F,
a AK :/1J-AKR/J
* AKR/J+(CBA/Ca-F,)
aAKR/J+AKR/J
0
1:1250 1:250 1 :50 1:1250 1:250 1:50 1:1250 1:250 1:50
Concentration of Anti-I-Ab mAb
Donors of purified CD4' cells
No. of
responders
Day of
assay
[3H]TdR
AKR/J
(H-2k)
incorporation with spleen stimulators
136 (B6 x CBA/Ca)Fl BALB/c
(H-26
) (H-26 x H-2k) (H-2,i)
x 10-' cpm x 10 ,
AKR/J -" (CBA/Ca - F:) FLC 2 4 0.7 10.7 3.6 27.3
2 5 2.0 23.8 11 .5 78.6
AKR/J - AKR/J FLC 0.5 4 0.1 2 .0 1 .2 1 .1
0.5 5 0.2 11 .4 3.8 3.2
1 4 0.5 11 .5 5.9 5.4
1 5 1 .6 35 .4 18.9 13.9
2 4 1 .8 39.9 25.3 24.2
2 5 4.1 80.6 65.0 64.7
Normal (B6 x CBA/J)Fi 2 4 1 .4 2 .0 1 .7 12.1
2 5 3.1 5 .9 3 .8 26.1to fourfold lowerdoses than the CD4' cells from the parent - F, chimeras (see Fig.
3 legend). The consistent finding (seen in three of three experiments) was that the
anti-B6 response of the parent (H-2k) - Ft chimera CD4+ cells was considerably
more sensitive to inhibition with anti-I-Ab mAb than the response of normal CD4+
cells. The simplest explanation for this finding is that the antihost MLR by the chi-
mera CD4+ cells was mediated by low affinity cells (see Discussion).
Skin Allograft Rejection.
￿
The stimulus for allograft rejection is known to be pro-
vided by "passenger leukocytes" (APC), especially la' cells of the dendritic cell lin-
eage (38). Since the skin ofparent - F, chimeras was essentially devoid of cells ex-
pressing a high density of host la molecules (Langerhans cells), it was of interest
to determinewhetherthe chimeras could reject normal host-type skin grafts. Thus,
if parent a - F, chimeras were grafted with normal parent b skin, would the strain
a CD4' cells generated in the chimeras respond to the strain b APC of the skin
grafts and lead to graft rejection? As shown in Fig. 4, experiments with both H-2k
-" F, and H-26 --> F, chimeras showed no evidence that the chimeras could reject
skin grafts of the opposite parental strain. All of the chimeras rejected control grafts
expressing third-party H-2 differences or isolated H-2 class 11 differences (bm12)
(Fig. 4). The chimeras also rejected minor H-different skin grafts, i.e., B6 - (B6 x
CBA/J)F) chimeras rejected CBA/Ca grafts but not CBA/J grafts (tested in one ex-
periment only; data not shown).
InductionofLethal GVHD.
￿
The twoexperiments shown in Table V were designed
to investigate whether CD4+ cells from parent - F, chimeras could elicit lethal
GVHD when transferred to normal host-type irradiated F, mice. The notable
finding was that transfer of high doses, i.e., 5 x 106, of the chimera CD4' cells to
host-type irradiated mice caused no mortality or signs of ill health. With transfer
of normal parental strain CD4' cells, by contrast, a 10-fold lower dose of CD4' cells
caused 100% mortality, and even a 50-fold lower dose of cells caused a significant
incidenceofGVHD, i.e., lethal GVHD in two of five mice and severe sublethalGVHD
in two of the remaining three mice. The chimera CD4+ cells and normal CD4' cells
both caused 100% mortalitywhen transferred to hosts expressing a third-party H-2
difference.
A
￿
B
￿
C
￿
FIGURE 4. Skin graft rejection by
parent - F, BM chimeras. Three ex-
periments with three different batches
of chimeras are shown, i.e., B6 --" F,
chimeras in A, AKR/J - F, chimeras
in B, and AKR/J - (CBA/Ca - F,)
chimeras in C. ForA and B, the chi-
meras were tested at 3 mo after irradi-
ation andBM reconstitution ; for C, the
twice-irradiated chimeras were tested
at 3 mo after the second dose of irradi-
ation. Each chimera received two to
three skin grafts taken from normal ho-
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mozygous donors. The type of skin
Skin Graft Survival Tlmo IdI
￿
grafts applied (arrow) andthe number
of grafts examined (parenthesis) are
shown in the figure. It is evident that the chimeras rapidly rejected grafts expressing third-party H-2
differences but failed to reject skin grafts of the opposite parental strain. These latter grafts remained
intact until the mice were killed at 2-4 mo after grafting.
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TABLE V
Lethal GVHD Mediated by CD4+ Cellsfrom CBA/Ca -.. F1 BMC
CD4' cells prepared from LN of long-term (6 mo) CBA/Ca - F, BM chimeras were transferred in-
travenously into irradiated (1,000 rad 1 d before) F, hosts together with a dose of 5 x 106 T cell-depleted
host-type BM cells.
' Two of the three surviving mice in this group developed severe GVHD before eventually recovering.
Tolerance in Thymocytes.
￿
In all of the experiments considered above, tolerance was
examined at the level of extrathymic T cells, usually LN cells. To examine whether
tolerance induction in the chimeras occurred intrathymically, thymocytes from the
chimeras were tested for reactivity to host-type stimulators in MLR. Since MLR
by unfractionated thymocytes are quite low, the thymocytes were treated with anti-
CD8 mAb + C to enrich for the mature component of CD4+ CD8- cells. Two ex-
periments with these cells are illustrated in Table VI. The striking finding was that
the CD8- thymocytes from parent -> F1 chimeras responded well to third-party
stimulators but showed near complete tolerance to stimulators expressing host-type
H-2 determinants. This finding clearly contrasted with the significant antihost MLR
mediated by CD4+ cells recovered from LN (Table VI, Exp. 2).
V,B11 Expression in LN vs. Thymus.
￿
The profound host tolerance seen at the level
of thymocytes raised the question whether clonal deletion of host-reactive T cells in
the chimeras was greater in the thymus than in the extrathymic tissues. To examine
this question, LN cells and thymocytes from parent - F, chimeras were tested for
expression of VOW T cells . Vpll+ T cells are selectively deleted in I-E+ mice (29);
the deletion of these cells is near complete for CD4+ cells but only partial for CD8+
cells (39).
As shown in Table VII, VOW cells accounted for 5-6% of CD4+ cells from I-E-
B6 and B6.PL LN, but only 0.1% of CD4+ cells from I-E+ (136 x CBA/J)Fl mice
Exp.
Donors of purified
LN CD4* cells
transferred with
host BM cells
No. of
CD4'
cells Recipients (1,000 rad)
H-2
stimulus
Dead/
alive
Mortality
Percent
dead
Mean
survival
time
x 10-6
1 CBA/Ca -" F, BMC 5 (136 x CBA/J)F, b 0/5 0 >100
5 (CBA/Ca x BALB/c)Fl d 5/5 100 8
Normal CBA/Ca 0.5 (136 x CBA/J)F, b 5/5 100 15
5 (136 x CBA/J)F, b 5/5 100 8
5 (CBA/Ca x BALB/c)F, d 5/5 100 15
(BM cells only) 0 (136 x CBA/Ca)Fl - 0/5 0 >100
0 (CBA/Ca x BALB/c)F, - 0/5 0 >100
2 CBA/Ca - F, BMC 5 (136 x CBA/Ca)Fl b 0/5 0 >100
5 (B10.D2 x 1310.13R)F, d 5/5 100 8
Normal CBA/Ca 0.1 (136 x CBA/Ca)F, 6 2/5 40 8,25,
>100'
0 .5 (136 x CBA/Ca)F, 6 5/5 100 7
5 (136 x CBA/Ca)F, 6 5/5 100 7
5 (B10.D2 x 1310.13R)F, d 5/5 100 19
(13M cells only) 0 (136 x CBA/Ca)F, - 0/5 0 >100
0 (1310.132 x 1310.13R)F, - 0/5 0 >100GAO ET AL.
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TABLE VI
MLR by CD8- Thymocytes from Parent - Fi BM Chimeras: Profound
Unresponsiveness to Host-type H-2 Determinants
In Exp. 1, line 1, the chimeras were assayed at 7 mo after reconstitution. For line 2, the chimeras were given
a single large dose ofanti-Thy-1 mAb (T24 ascites; 0.2 ml/mouse, i .p.) 3 mo after irradiation and BM recon-
stitution, and tested 4 mo after the anti-Thy-1 treatment. For line 3, CBA/Ca -" F, chimeras received a
second dose ofirradiation (900 rad) plus more CBA/Ca BM cells at 3 mo after initial irradiation; the chimeras
were assayed at 4 mo after the second dose of irradiation . In Exp. 2, line 2, 136 - F, chimeras received
a second dose of irradiation (900 rad) plus T-depleted B6.PL BM cells at 6 mo after initial reconstitution;
the chimeras were assayed at 5 mo after secondary reconstitution. For use as respondercells in MLR, thymocyte
suspensions were treated with anti-CD8 mAb plus C, and LN cells were treated with anti-CD8 and Jlld plus
C before culture. T-depleted spleen cells exposed to 1,500 rad were used as stimulator cells ( 5 x 105/culture).
(the hostsused forpreparingthe chimeras). Incontrol experimentswithdouble BM
chimeras, i.e., CBA/Ca + B6 - Ft chimeras (Table VII, line 3), the B6-derived
(H-2Kk-) LN CD4+ cells differentiating in these chimeras showed a virtual absence
ofVa11+ cells (<O.l%). By contrast, the CD4+ cells differentiating in H-2b -" F1 chi-
meras showed incomplete deletion ofVg11+ cells. In these chimeras, Va11 + cells ac-
counted for 1-2% ofLN CD4+ cells, i.e., -70% less than for CD4+ cells from nor-
mal parental strain H-2b mice (5-6%). The deletion of Va11 + CD8+ cells in the
chimeras was variable but tended to be less extensive than for CD4+ cells.
Va11 expression in the thymus was examined at the level ofmature thymocytes,
using either CRT or normal thymocytes treated with anti-CD8 mAb + C (Table
VII). As in LN, mature V#11 + CD4+ cells were prominent in the thymus of I-E -
H-2b (B6YL) mice (ti4%) but were rare in I-E+ (B6 x CBA/J)Fi mice (<0.4%).
Significantly, Vall+ CD4+ cells were clearly detectable in the thymus of B6.PL -->
Ft chimeras (1-2%), the proportion ofthese cells in the thymus being no lowerthan
in LN. The marked unresponsiveness ofthymocytes to host H-2 antigens in MLR
thus failed to correlate with the extent ofclonal deletion of VS11 + CD4+ cells.
Exp
Cell
donors
Cells tested
(105)
Day of
assay
[SH]TdR incorporation
with spleen stimulators
CBA/Ca B6 BALB/c
(H-2k) (H-26) (H-211)
cpm x 103
1 CBA/Ca - F, BMC CD8 - thymus 5 0.3 0.2 18.4
CBA/Ca - F, (anti-Thy-1 mAb) CD8 - thymus 5 0.2 0.3 23.0
BMC
CBA/Ca - (CBA/Ca -" F,) CD8 - thymus 5 0.1 0.2 16.0
BMC
CBA/Ca B6.PL bm12
(H-2 k) (H-26) (H-26-12)
2 Normal B6.PL CD8 - thymus 5 78.0 0.3 39.1
B6TL - (B6 -.. F,) BMC CD8 - thymus 5 1 .8 0.4 30.8
6 3.2 0.2 62.7
CD4 ` LN 5 13.6 1 .6 89.6
6 63.6 1 .5 10.41114
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TABLE VII
V,611 Expression by LN Cells and Thymocytes from Parent - F1 BM Chimeras
Cell suspensions (pooled from one to two mice) were obtained from chimeras at 4-6 mo post-reconstitution
or at 3-4 mo after the second dose ofirradiation for twice-irradiated chimeras. Cell suspensions were stained
with anti-Vo mAb plus FITC-anti-Ig mAb followed by biotinylated anti-CD8 plus PE-streptavidin or PE-
anti-CD4 (Materials and Methods). Stained cells were analyzed by flow cytometry. CRT were also stained
with FITC-labeled anti-CD3 mAb vs. PE-anti-CD4 mAb; the data for CRT were calculated with respect
to CD3h' cells.
Discussion
The notion that T cell tolerance to H-2 determinants reflects early Tcell contact
with BM-derived cells rather than thymic epithelium predicts that Tcells differen-
tiating in parent - F1 chimeras completely depleted ofhost BM-derived cells would
not displaytoleranceto host-type H-2 determinants. Totest thisprediction, we made
concerted efforts to ensure that the chimeras examined for T cell tolerance were
thoroughly depleted ofhost-type BM-derived cells. Byall parameters tested, includ-
ing staining cryostat sections with anti-la mAb, searching for cells able to stimulate
primary MLR, and FAGS analysis oflymphoid suspensions, the chimeras were es-
sentially devoid ofcells with the typical properties ofAPC. Radioresistant host T
cells were evident in chimeras given a single dose ofirradiation, but these cells dis-
appeared after secondary irradiation. Although host-type APC were undetectable
inchimeras at2 mo after asingle dose ofirradiation(1,300 rad), many ofthe chime-
rastested fortolerance were subjectedto secondaryirradiation and BM reconstitution.
Despite the apparent absence ofhost-type APC, the T cells differentiating in par-
ent -" F1 chimeras showed profound tolerance to host-type H-2 determinants. With
the exception of the antihost MLR mediated by CD4+ cells, tolerance to host H-2
determinants appeared to be complete in the three other assay systems tested, i.e.,
MLR by CD8+ cells (t IL-2), skin allograft rejection, and lethal GVHD elicited
by CD4+ cells. In speculating on the mechanism oftolerance induction in the chi-
meras, the key issue is whether tolerance was induced in the thymus or in the post-
thymic environment.
Cell donors Cells tested
No. of
experiments
Percent
CD4'8- cells
expressing
Voll V08
Percent
CD4 - 8' cells
expressing
Vol 1 V08
B6 - F, BMC Unseparated LN 2 1 .6 18 .4 6 .2 18.4
B6.PL - (B6 - Ft) BMC Unseparated LN 1 1 .4 14.9 4.6 17 .6
CBA + B6 - F, BMC Unseparated LN 1 <0.1 16 .9 2.8 23 .9
Normal B6 Unseparated LN 3 5 .7 18.0 7.5 16.4
Normal B6.PL Unseparated LN 3 5 .3 14.9 7.2 14.6
Normal (B6 x CBA/J)Fl Unseparated LN 4 0.1 16 .2 3.0 14.3
B6.PL - F, BMC J1ld - CD8 - LN 3 1 .2 17.9 - -
Normal B6.PL Jlld - CD8 - LN 3 5.3 16.7 - -
Normal (B6 x CBA/J)Fl Jlld - CD8 - LN 3 <0.1 14.8 - -
B6.PL - (B6 -" F,) BMC CRT 1 1 .6 14.5 5.3 13 .9
Normal B6 .PL CRT 1 3 .5 17 .7 6.5 11 .2
Normal (B6 x CBA/J)Fl CRT 1 <0 .1 14 .8 6.4 14.9
B6.PL - Fj BMC CD8 - thymus 3 1 .6 16 .8 - -
Normal B6.PL CD8 - thymus 3 4 .4 16 .3 - -
Normal (B6 x CBA/J)Fl CD8 - thymus 3 0.4 18.2 - -GAO ET AL.
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For CD8' cells, tolerance could have occurred largely in the post-thymic envi-
ronment, i.e., through exposure to the dense array of class I molecules expressed
on host stromal(non-BM-derived) cells. Class Iexpression on these"nonprofessional"
APC might be strongly tolerogenic, e.g., viaa veto effect (40). The critical question
is whether tolerance of CD8' cells in parent - F, chimeras is evident at the level
of mature thymocytes. This question is currently under investigation.
Extrathymic tolerance of T cells in parent - Fi chimeras is presumably less likely
for CD4' cells than CD8' cells because the density of class II (Ia) expression on
most non-BM-derived cells is quite low. To seek direct evidence on whether toler-
ance of CD4+ cells can occur in thepost-thymic environment, we have recently been
studying tolerance in thymectomized irradiated (a x b)F1 mice given parent a BM
cells and a parent a thymus graft. Provided that the thymus grafting was delayed
for several months post-irradiation to allow disappearance of host APC, the strain
a CD4' cells differentiating in the strain a thymus grafts showed no detectable tol-
erance to host strain b H-2 (la) antigens (Gao, E. K., and J. Sprent, manuscript
submitted for publication). These findings make it unlikely that the tolerance of
CD4' cells seen in the present study was induced extrathymically.
If the tolerance of the chimera CD4' cells occurred intrathymically, one would
expect to find evidence of tolerance at the level of thymocytes. The striking finding
here was that the population of mature CD4' (CD8 -) cells recovered from the thy-
mus of parent - Fl chimeras manifested almost total tolerance to host-type APC
in primary MLR. Whatever the explanation for the completeness of tolerance in
the thymus relative to LN (see below), these data would seem to provide firm evi-
dence that the CD4' cells in the chimeras were tolerized within the thymus itself.
Since thymocyte suspensions from parent - Fi chimeras were essentially devoid
of typical host-type APC (Table 1), we think it unlikely that the tolerance of CD4'
(CD8-) thymocytes to host H-2 antigens reflected intrathymic contact with resid-
ual host APC. Nevertheless, one has to consider the objection that a few host APC
survived in situ but failed to enter the thymocyte suspensions used for measuring
APC function in vitro. Although this remains a formal possibility, it is notable that
strong intrathymic tolerance was observed in double-irradiated chimeras with a pro-
longed (6 mo) period between the two doses of irradiation. Since functional host
APC disappeared rapidly (and apparently completely) in hosts prepared with only
a single dose of irradiation, it is difficult to sustain the argument that intrathymic
survival ofhost APC accounted forthe tolerance seen in the twice-irradiated chime-
ras. For this reason, we think it much more likely that tolerance reflected contact
with thymic epithelial cells(and/or otherradioresistant non-BM-derived thymic com-
ponents).
The notion that thymic epithelial cells control tolerance induction in BM chime-
ras clearly contrasts with the prevailing view that thymic epithelium makes little
or no contribution to tolerance induction. On this point, it should be emphasized
that a number of groups have claimed that thymic epithelium is at least partly tol-
erogenic for newly formed T cells (13-17). The main objection to these claims has
been that the tolerance seen in these studies might have reflected contact with con-
taminating BM-derived cells. It should be stated, however, that the evidence that
epithelial cells are completely nontolerogenic rests largely on studies with CD8' cells
differentiatingin nude mice bearingthymus grafts treated with deoxyguanosine (dguo)1116
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(an effective method for depleting thymuses of APC). The unequivocal finding in
this model is that, in the presence ofexogenous lymphokines, CD8' CTL precur-
sors differentiating in strain a nude mice given dguo-treated strain b thymus grafts
show no detectable tolerance to strain b H-2 determinants (9, 10). We have recently
confirmed this finding (Webb, S., andJ. Sprent, manuscript submitted for publica-
tion). However, in marked contrast to CD8+ CTL, we observed that the CD4' cells
developing in nude mice bearing dguo-treated thymus grafts exhibited quite strong
tolerance to graft-type APC in primary MLR. Interestingly, as in parent - F, chi-
meras (this paper), the tolerance of CD4' cells in the thymus-grafted nude mice
was partial for LN CD4' cells but near complete for CD4+ (CD8-) thymocytes.
Collectively, the data from parent --" F1 chimeras and dguo thymus-grafted mice
would seem to make a strong case that thymic epithelium is capable of inducing
conspicuous tolerance at the level ofCD4+ cells. In speculating on the mechanism
of tolerance induction by thymic epithelium, three questions arise.
WhyAre Thymic Epithelial CellsLess Tolerogenic than BM-derived Cells?
￿
Although tol-
erance induction in parent --> F, chimeras appeared to be complete by certain pa-
rameters, e.g., skin graft rejection and induction oflethal GVHD, CD4' LN cells
from the chimeras invariably gave significant antihost responses in primary MLR.
The possibility that the antihost MLR simply reflected incomplete elimination of
mature T cells from the donor BM inoculum seems unlikely because the response
exhibited normal kinetics and was evident with chimeras prepared with very early
(day 13) fetal livercells. Although the magnitude oftheantihost MLR was variable,
the responses were generally N70% lower than the responses mediated by normal
parental strain CD4' cells. In this respect, it is of interest that the CD4+ cells de-
veloping in I-E- --> I-E' chimeras showed -70% reduction in VOW cells. Although
the correlation between the extent ofVa11' cell deletion and the magnitude ofthe
antihost MLR mightbe fortuitous, the data clearly imply that the thymic epithelial
cells ofthe chimeras did not tolerize all host H-2-reactive CD4' cells. For full tol-
erance induction, contact with host H-2 determinants on APC appeared to be es-
sential. This is evident from the finding that, in contrast to chimeras prepared with
BM cells from one parental strain, T cells differentiating in double BM chimeras
(a + b BM - Fj) showed complete tolerance in MLR and total elimination of
VR11' cells (Tables III and VII).
Two models might explain why thymic epithelium is less tolerogenic than BM-
derived cells. The first model rests on the assumption that H-2 tolerance is not di-
rected to H-2 epitopes per se but to various self peptides held in the binding site
of H-2 molecules. Marrack and Kappler (41) have suggested that APC and thymic
epithelial cells express a different range of selfpeptides. Accordingly, one could ar-
gue that thymic epithelial cells are fully capable of tolerizing T cells reactive to the
particular H-2/peptide complexesexpressed on epithelial cellsbut are unable to tol-
erize other T cells, i.e., T cells reactive to selfpeptides displayed only on APC and
not on thymic epithelium . In the absence ofAPC, these latter T cells escape toler-
ance induction and are allowed to exit from the thymus and reach maturity. These
T cells now manifest immunity to APC and mount proliferative responses when
exposed to APC in vitro. The antihost MLR mediated by LN CD4' cells from par-
ent F, chimeras is thus readily explained.GAO ET AL.
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The chief problem with this scenario is that it fails to explain why CD4' cells
from parent --> Ft chimeras displayed complete tolerance in some assays. In light
ofthe discrepancy between the level oftolerance seen in MLR vs. other assays, we
favor the view that the cells that escape tolerance induction by thymic epithelium
are simply low affinity T cells. Our suggestion here is that thymocytes with high
binding affinity for H-2 epitopes (or H-2/self peptide complexes) are very sensitive
to tolerance induction and can betolerized through contact with H-2 molecules ex-
pressed either on APC or on thymic epithelium. Low affinity T cells, by contrast,
are relatively resistant to tolerance induction (e.g., because ofpoor binding to the
tolerizing cells). These T cells can only betolerized byAPC and not bythymic epi-
thelium (perhaps because APC express a higher density of H-2 molecules and/or
of certain accessory molecules). When released into the extrathymic environment
ofparent - F1 chimeras, these low affinity T cells can proliferate when exposed to
APC in vitro but are incapable ofdifferentiating into effector cells, e.g., cells able
to elicit GVHD. The proliferative response is thus "sterile."
Although this model accommodates the main features ofthe split tolerance seen
in parent - Fl chimeras, the model relies heavily on several unproven assumptions,
especially the notion that high affinity T cells are required for some responses (e.g.,
skin graftrejection and GVHD induction), but not others (MLR). The chiefprob-
lem with the model, however, is that it is basically untestable, given that there are
currently no direct methods available formeasuring Tcell affinity. The findingthat
the antihost MLR by the chimera CD4' cells showed heightened susceptibility to
inhibition with anti-I-A' mAb is consistent with the view that the residual host-
reactive cells were oflow affinity, but we do not wish to overinterpret this finding.
Why Is the ToleranceInducedby Thymic Epithelium More Marked within the Thymus than
in the Extrathymic Environment? Since the deletion ofV,611' cells in I-E- - I-E+ chi-
meras was no more marked in thymus than LN, the profound functional tolerance
observed in mature CD4' (CD8") thymocytes cannot be attributed solely to clonal
deletion. The explanation we currently favor is that T cell contact with host H-2
antigens on thymic epithelial cells in the absence of host-type APC can result in
two different forms of tolerance: clonal deletion and a temporary form ofanergy.
Since the deletion of Vpll+ cells in the chimera thymocytes was considerable
(50-70%), the thymic epithelial cells ofparent - Ft chimeras presumably tolerize
most host-reactive Tcells by a mechanismthat involves clonal deletion. We envisage
that the remainder of the host-reactive T cells (perhaps low affinity cells) receive
a downregulation signal from thymic epithelium. Tcells affected by this signal are
rendered anergic and display unresponsiveness when exposed to host APC in vitro.
In the absence ofhostAPC in thethymus, this subset ofT cells is allowed to survive
and exit to the periphery. Here the T cells rapidly recover from their anergic state
andnow manifest immunity (display an antihostMLR)when exposed to host APC.
The above scheme rests on the assumption that, when tested in MLR, the CD4'
(CD8-) thymocytes from the chimeras remained in a refractory (anergic) state when
cultured with host-type APC. The alternative possibility is that contact with host
APC in vitro caused the Tcells to undergo rapid destruction. If this were the case,
one could envisage that contact with thymic epithelium does not induce anergy but
simply makes the T cells hypersensitive to the tolerogenic effects ofAPC. To assess1118
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this second possibility, we are in the process of testing whether exposure ofthe chi-
mera thymocytes to host APC in vitro results in rapid elimination of the residual
VQ11' cells.
Which Population of Thymic Epithelium Controls Tolerance Induction?
￿
Since the main
function ofthymic epithelium is presumably to control positive selection ofTcells,
the evidence that thymic epithelium also contributesto negative selection (tolerance)
raises the question whether these two opposing functions operate in the same mi-
croenvironment of the thymus. Most groups have assumed that positive selection
of T cells is controlled by cortical epithelial cells (3-7, 41), and direct support for
this idea has come from recent studies with the AY line oftransgenic mice (which
expresses transgenic I-E molecules in cortical epithelium but not in medullary epi-
thelium) (42). It isquite conceivable thatcortical epithelial cellsalsoinduce negative
selection. However, itis equally possible thatthe tolerogenicity ofthymic epithelium
is controlled bytheepithelial componentofthe medulla(12). Inthis respect, it should
be noted that, although some medullary epithelial cells are reported to be Ia- (43),
the medulla oflong-term parent - F, chimeras contains dense aggregates ofkera-
tin-positive cells that coexpress a very high density of host la molecules (unpub-
lished dataofthe authors). It istempting to speculate thatthispopulation ofmedul-
lary epithelial cells plays an important role in negative selection. The two opposing
functions ofthymic epithelial cells might then be strictly compartmentalized with
positive selection being controlled by cortical epithelium and negative selection in-
duced by medullary epithelium . Direct evidence on this question is needed.
Summary
T cell tolerance induction was examined in long-term H-2-heterozygous parent
-~ Fj chimeras prepared with supralethal irradiation (1,300 rad). Although these
chimeras appeared to be devoid ofhost-type APC, the donor T cells developing in
the chimeras showed marked tolerance to host-type H-2 determinants. Tolerance
tothe host appearedto bevirtuallycomplete in four assay systems: (a) primarymixed
lymphocyte reactions (MLR) of purified lymph node (LN) CD8' cells (± IL-2);
(b) primary MLR ofCD4' (CD8-) thymocytes; (c) skin graft rejection; and (d) in-
duction oflethal graft-vs.-host disease by CD4' cells. Similar tolerance was observed
in chimeras given double irradiation. The only assay in which the chimera T cells
failed to show near-total tolerance to the host was the primary MLR ofpost-thymic
CD4' cells. In this assay, LN CD4' cells regularly gave a significant antihost MLR.
The magnitudeofthisresponse wastwo- to fourfold less thanthe responseofnormal
parental strain CD4' cells and, in I-E- -" I-E' chimeras, was paralleled by -70%
deletion of V011' cells.
Since marked tolerance was evident at the level ofmature thymocytes, tolerance
induction in the chimeras presumably occurred in the thymus itself. The failure
to detect host APC in the thymus implies that tolerance reflected contact with thy-
mic epithelial cells (and/or other non-BM-derived cells in the thymus). To account
for the residual host reactivity of LN CD4' cells and the incomplete deletion of
Voll' cells, it is suggested that T cell contact with thymic epithelial cells induced
clonal deletion ofmost of the host-reactive T cells but spared a proportion ofthese
cells (possibly low affinity cells). Since these latter cells appeared to be functionally
inert in the thymus (in contrast to LN), we suggest that the thymic epithelial cellsGAO ET AL.
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induced atemporary form of anergy in the remaining host-reactive thymocytes. This
anergic state disappeared when the T cells left the thymus and reached LN.
Receivedfor publication 7 September 1989 and in revised form 19 December 1989.
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